Vol 9, No 4 (2012)

Articles
Primary idiopathic hyperaldosteronism in clinical practice
., .
Abstract
Primary hyperaldosteronism (PHA) is a clinical syndrome that develops as a result of excess production of aldosterone by adrenal glomerular zone, where aldosterone secretion is completely or partially autonomous in relation to the renin-angiotensin system. This factor leads to the development low renin arterial hypertension (AH). Primary idiopathic hyperaldosteronism is one of the forms of PHA. The prevalence of this form is variously estimated from 20 to 55% of patients with PHA. Morphological substrate primary idiopathic hyperaldosteronism is a bilateral micro- or macronodular adrenal hyperplasia. This article summarizes the contemporary view of the pathogenesis, clinical presentation, diagnosis and treatment of idiopathic hyperaldosteronism.
Obesity and metabolism. 2012;9(4):3-9
views
Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
.
Abstract
The article presents the results of clinical studies on the efficacy and safety of androgen therapy for metabolic syndrome and obesity in men with hypogonadism. The study is focused on the use of testosterone undecanoate for reduction of body fat and the severity of other components of the metabolic syndrome, improvement of sexual function without causing severe side effects. In a number of patients treated we observed suppression of spermatogenesis, which prevents the use of the drug in the reproductive rehabilitation.
Obesity and metabolism. 2012;9(4):10-13
views
Continuous monitoring of blood glucose in the practice of endocrinologist
.
Abstract
Continuous glucose monitoring - an important diagnostic, teaching and treatment tool for patients with diabetes mellitus, which is increasingly becoming a part of routine clinical practice in endocrinology. This article presents an overview of modern techniques, their advantages and disadvantages, evidence basis and place in everyday clinical practice. The article discusses the key factors affecting the efficiency, indications, contraindications, conditions of use of the continuous glucose monitoring systems in patients with diabetes mellitus, gives an algorithm for the application of this technique in clinical practice.
Obesity and metabolism. 2012;9(4):15-22
views
Vitamin D 3, osteoprotegerin and other hormonal and metabolic parameters in female patients with type 2 diabetes
., ., ., .
Abstract
The article presents the results of evaluation of vitamin D3, osteoprotegerin, carbohydrate and fat metabolic parameters in women with type 2 diabetes and obesity. The study subjects showed an increase of osteoprotegerin, decrease of vitamin D3, insulin resistance and compensatory hyperinsulinemia.
Obesity and metabolism. 2012;9(4):23-27
views
Medical and social characteristics of persons with adverse cardiometabolic risk profile
., ., .
Abstract
The study evaluated the effectiveness of screening tests performed on the basis of functioning centers of Health, to identify individuals with cardiometabolic risk factors. Materials and methods: A total of 2007 men (mean age 50,80±16,54 years) were evaluated. The results of physical and psychological tests, express-analysis of functional state of heart via ECG, express-analysis of cholesterol and glucose blood levels, vascular screening, and concentration of carbon monoxide, carboxyhemoglobin and human body composition by bioimpedance were estimated. Results: During the screening we revealed 62.33% men with BMI≥25 kg/m2. BMI≥25 kg/m2 was associated with an increase in the average levels of cholesterol, fasting blood glucose, blood pressure, as well as signs of myocardial electrical instability and autonomic dysfunction. Progressive increase in BMI≥25 kg/m2 was associated with the presence of combined cardiometabolic risk factors and the presence of unhealthy lifestyle behaviors. All patients with a BMI≥25 kg/m2 received individual recommendations about a mode of work, physical activity and diet, and were also invited for group training in «Weight reduction school»
Obesity and metabolism. 2012;9(4):28-33
views
Relationship of obesity with the main reproductive parameters in men-residents of Novosibirsk (Russia)
.
Abstract
A link between obesity, overweight and reproductive performance in male volunteers 18 to 40 years (n=261), living in the city of Novosibirsk was investigated. Hormone levels (follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T), oestradiol (E2), inhibin B) and main indicators of semen quality (concentration, percentage of motile and morphologically normal sperm) were evaluated in each patient. Following groups were retrospectively formed: the control (group 1, a BMI of 18.5 to 24.9 kg/m2, n=50), overweight men (group 2, a BMI of 25.0 to 29.9 kg/m2, n=28), obese men (group 3, a BMI greater than 30.0 kg/m2, n=5). The exclusion criteria from the analysis were as follows: andrological disease (prostatitis, epididymal cyst, varicocele, sexually transmitted infection), transferred surgery of andrological diseases. A reduction in the testosterone serum concentration was found along the groups in the direction 1->2->3 respectively, 23.3->15.7->11.8 nmol/L (р1,2=0.006; р1,3=0.0001). Semen volume was statistically reduced in obese men compared with normal weight men (p1,3=0.019). There were no significant differences in age, FSH, LH, E2, Inhibin B levels, concentration, motility, percentage of morphologically normal sperm between groups. The findings show the distinct hypoandrogenia in young men with overweight and obesity. A testosterone deficiency is increased with increasing BMI and the testosterone concentration descends to less than 12 nmol/L in the obesity group, which corresponds to hypogonadism.
Obesity and metabolism. 2012;9(4):34-38
views
Dynamics of adipose tissue changes measured by MRI in obese patients during Reduxin treatment
., ., .
Abstract
Objective. To study the influence of the drug Reduxine in obese patients on the distribution of adipose tissue measured by MRI. Methods. In an open, prospective, non-randomized study duration of 20 weeks included 31 obese patients aged 20 to 65 years. During the study, the anthropometric parameters and the dynamics of the area of adipose tissue by means of MR imaging. Results. Weight loss in patients averaged 9.0 kg. Clinically significant weight loss reached 23 people (79%). Median reduction in waist circumference was 10 cm. Dynamic assessment of adipose tissue by MRI was performed in 17 patients. Reduxine treatment induced statistically significant decrease of both visceral and subcutaneous fat. Conclusions. According to the results of MRI, the reduction in waist circumference in patients receiving Reduxine occurred by reducing the number of both subcutaneous and visceral fat in the abdominal area.
Obesity and metabolism. 2012;9(4):39-43
views
Clinical case: multiple endocrine neoplasia type 1 (MEN 1)
., ., ., ., .
Abstract
Multiple endocrine neoplasia syndrome type 1 (MEN1, Wermer syndrome) – group o а heterogeneous inherited deseases, caused by hyperlasia or neoplasia of several endocrine glands. The phenotype of MEN1 is broad, and over 20 different combinations of endocrine and non-endocrine metabolic manifestations have been described. This case demonstrates multiple formations of endocrine organs, starting non-classical with macroprolactonoma resistant to dopamine agonists therapy, other endocrine disorders developed gradually eventually: hyperparathyreoidism and hypoglycemia caused by pancreas lesions, produced proinsulin in high levels.
Obesity and metabolism. 2012;9(4):44-47
views
The use of cabergoline for treatment of syndrome of ovarian hyperstimulation
.
Abstract
Реферат по статье: Kalampokas T, Creatsas G, Kalampokas E. Cabergoline as treatment of ovarian hyperstimulation syndrome: a review. Gynecol Endocrinol. 2013 Feb;29(2):98-100. doi: 10.3109/09513590.2012.730578. Epub 2012 Oct 30.
Obesity and metabolism. 2012;9(4):48-50
views
An antiinflammatory actions of exenatide
.
Abstract
Реферат по статье: Chaudhuri A, Ghanim H, Vora M, Sia CL, Korzeniewski K, Dhindsa S, Makdissi A, Dandona P. Exenatide exerts a potent antiinflammatory effect. J Clin Endocrinol Metab. 2012 Jan; 97(1): 198-207.
Obesity and metabolism. 2012;9(4):52-53
views
How weight is associated with mortality in diabetes mellitus patients
.
Abstract
Реферат по статье: Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012 Aug 8;308(6):581-90.
Obesity and metabolism. 2012;9(4):54
views
Constitutive insulin sensitivity and obesity my be caused by PTEN mutations
.
Abstract
Реферат по статье: Pal A, Barber TM, Van de Bunt M, Rudge SA, Zhang Q, Lachlan KL, Cooper NS, Linden H, Levy JC, Wakelam MJ, Walker L, Karpe F, Gloyn AL. PTEN mutations as a cause of constitutive insulin sensitivity and obesity. N Engl J Med. 2012 Sep 13;367(11):1002-11.
Obesity and metabolism. 2012;9(4):55
views
Long term treatment with metformin in patients with type 2 diabetes and vitamin B 12
.
Abstract
Реферат по статье: De Jager J, Kooy A, Lehert P, Wulffelé MG, van der Kolk J, Bets D, Verburg J, Donker AJ, Stehouwer CD. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010 May 20;340:c2181.
Obesity and metabolism. 2012;9(4):56-57
views
Increase in overall mortality risk in patients with type 2 diabetes receiving different oral diabetes drugs
.
Abstract
Реферат по статье: Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS. Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis. Diabetes Obes Metab. 2012 Sep;14(9):803-809.
Obesity and metabolism. 2012;9(4):58
views
Characteristics of failed fertilized oocytes in patients with severe obesity
.
Abstract
Реферат по статье: Machtinger R, Combelles CM, Missmer SA, Correia KF, Fox JH, Racowsky C. The association between severe obesity and characteristics of failed fertilized oocytes. Hum Reprod. 2012 Nov;27(11):3198-207.
Obesity and metabolism. 2012;9(4):60
views
Fenofibrate reduces food intake via cholecystokinin
.
Abstract
Реферат по статье: Park MK, Han Y, Kim MS, Seo E, Kang S, Park SY, Koh H, Kim DK, Lee HJ. Reduction of Food Intake by Fenofibrate is Associated with Cholecystokinin Release in Long-Evans Tokushima Rats. Korean J Physiol Pharmacol. 2012 Jun;16(3):181-6.
Obesity and metabolism. 2012;9(4):61-62
views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies